Alzheimer's risk gene impairs development of new neurons in mice

July 30, 2018, Society for Neuroscience
ApoE-expressing astrocytes (green) interacting with tdTomato-expressing dendrites (red) from adult newborn hippocampal neurons. Credit: Tensaouti et al., eNeuro (2018)

Scientists have taken a step closer to understanding how the strongest known genetic risk factor for Alzheimer's disease (AD) contributes to memory impairment. Reporting their findings in eNeuro, the researchers demonstrate a critical role of the risk gene in the proper development of adult-born neurons in the hippocampus.

Apolipoprotein E (ApoE) is among the genes that regulate ongoing generation of neurons in the dentate gyrus of the . A variant of this gene called ApoE4—present in 10 to 20 percent of the human population—is also associated with the development of late-onset AD.

Investigating the effects of ApoE on adult neurogenesis, Tzong-Shiue Yu, Steven Kernie, and colleagues found reduced complexity of the dendrites of adult-born neurons in mice with genetically silenced ApoE compared to unaltered mice, as well as in those expressing ApoE4 compared to ApoE3-expressing mice—ApoE3, the most common variant found in humans, is not associated with disease risk.

These findings suggest a potential explanation for the increased risk of neuropsychiatric diseases involving the hippocampus, including AD, among ApoE4 carriers.

Explore further: Neuroscientists discover roles of gene linked to Alzheimer's

More information: ApoE regulates the development of adult newborn hippocampal neurons, eNeuro, DOI: 10.1523/ENEURO.0155-18.2018

Related Stories

Neuroscientists discover roles of gene linked to Alzheimer's

May 31, 2018
People with a gene variant called APOE4 have a higher risk of developing late-onset Alzheimer's disease: APOE4 is three times more common among Alzheimer's patients than it is among the general population. However, little ...

Unraveling genetic risk factors for Alzheimer's disease

July 2, 2018
The strongest genetic risk factor for Alzheimer's disease may impair the brain's ability to convert its primary fuel source into usable energy, finds a study of female mice published in JNeurosci. The research suggests therapeutic ...

Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target

September 20, 2017
Nearly a quarter century ago, a genetic variant known as ApoE4 was identified as a major risk factor for Alzheimer's disease—one that increases a person's chances of developing the neurodegenerative disease by up to 12 ...

Scientists fix genetic risk factor for Alzheimer's disease in human brain cells

April 9, 2018
Using human brain cells, scientists at the Gladstone Institutes discovered the cause of—and a potential solution for—the primary genetic risk factor for Alzheimer's disease, a gene called apoE4.

Gene variant may increase psychiatric risk after traumatic brain injury

May 14, 2018
A variant of the APOE gene may be linked to worse psychiatric symptoms in people who have had a traumatic brain injury, found a Veterans Affairs San Diego Healthcare System study. Study participants with both the gene variant ...

Recommended for you

Genetic changes tied to rare brain bleeds in babies

December 18, 2018
(HealthDay)—Researchers say they've identified genetic mutations linked with a blood vessel defect that can lead to deadly brain bleeds in babies.

What prevents remyelination? New stem cell research reveals a critical culprit

December 18, 2018
New research on remyelination, the spontaneous regeneration of the brain's fatty insulator that keeps neurons communicating, could lead to a novel approach to developing treatments for multiple sclerosis (MS) and other inflammatory ...

Gene variant found in brain complicit in MS onset

December 18, 2018
Multiple sclerosis (MS) is an autoimmune disease affecting the function of the central nervous system. Up to now, most of the 230 genetic variants associated with the disease have been linked to changes in immune cells. However, ...

Biologists identify promising drug for ALS treatment

December 18, 2018
A drug typically used to treat hepatitis could slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta scientists.

Communication between neural networks

December 18, 2018
The brain is organized into a super-network of specialized networks of nerve cells. For such a brain architecture to function, these specialized networks – each located in a different brain area – need to be able to communicate ...

Tiny implantable device short-circuits hunger pangs, aids weight loss

December 17, 2018
More than 700 million adults and children worldwide are obese, according to a 2017 study that called the growing number and weight-related health problems a "rising pandemic."

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.